The $99 no-needle blood test men are using to track testosterone
A military-backed startup's button-sized device is reshaping at-home hormone testing, and telehealth giants are racing to adopt it.

Loading the Newsroom
Curating from trusted global sources…
172 briefings · “ev”
A military-backed startup's button-sized device is reshaping at-home hormone testing, and telehealth giants are racing to adopt it.
Two new Bee devices turn real conversations into summaries, reminders, and personalized shopping picks via Alexa+ and Amazon.com.
The actor, who lost big on a NYSE-listed gym chain, is back with a budget longevity club that bundles cold plunges, blood panels, and protein muffins.
Apple's first foldable starts at $1,999, and preorder demand is so strong that orders are slipping into 2027, reshaping the foldable market and your upgrade cycle.
The streaming giant's sudden shake-up is a signal to every media executive: narrative and engagement now outweigh internal stability.
The backlash over playoff ads raises a governance question: who is accountable for MLB's commercial partnerships as gambling and wellness products hit the airwaves?
A base camp in Alaska is rewriting the timeline of the first Americans, with the oldest house, needles, and possible dog bones ever found in the Western Hemisphere.
A decade after Elizabeth Holmes's startup collapsed, a viral documentary has reignited the Theranos story, while researchers remind founders that hype is no substitute for proof.
The former Fox and Disney executive brings a playbook of prestige TV, live sports, and theatrical hits. Here is what his arrival means for Netflix's next era.
The researcher's new book argues standardized AI tests are fundamentally broken, but he says they can be rebuilt into a real science.
The Tesla CEO's latest reveal came at SpaceX, not Tesla, signaling where vertical mobility is headed.
The billionaire claims the world's first flying car, but the real stakes are the regulatory scramble and the blurring line between auto and aerospace.